Where is Topas headquartered?

Topas is located in Hamburg, hamburg.

Who invested in Topas?

Topas has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Topas?

Topas closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

topas-therapeutics.com

Topas

Topas is a Germany-based biotechnology company that develops and commercializes nanoparticle-based therapeutics for the treatment of autoimmune diseases and allergies.

Business Model:

Revenue: $3.5M

Employees: 11-50

Geographic Data

Address: Falkenried 88

City: Hamburg

State: hamburg

Zip: 20251

Country: DE

Financial Info

Stage:

series b

Raised Last:

$21M

Raised Total:

$68M

Social

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Topas is a Germany-based biotechnology company that develops and commercializes nanoparticle-based therapeutics for the treatment of autoimmune diseases and allergies.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2016	Series A		$0	EMBL Ventures Epidarex Capital Gimv EMBL Ventures Epidarex Capital Gimv
10/2020	Series B		$0	BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Gimv Vesalius Biocapital Partners BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Gimv Vesalius Biocapital Partners
10/2020	Series B		$26M	Vesalius Biocapital III BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Evotec Gimv
11/2017	Series A	1	$4.7M	Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund
11/2017	Series A		$4.7M	Boehringer Ingelheim Venture Fund
3/2016	Series A		$16.5M	Epidarex Capital EMBL Ventures Gimv Evotec
7/2021	Series B		$22M	BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Evotec GIMV Vesalius Biocapital III
7/2021	Series B		$0	BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Evotec Gimv Vesalius Biocapital Partners BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Evotec Gimv Vesalius Biocapital Partners
7/2021	Series B	7	$21.4M	BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Evotec Gimv Vesalius Biocapital Partners BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Evotec Gimv Vesalius Biocapital Partners
10/2020	Series B	6	$25.9M	BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Gimv Vesalius Biocapital Partners BioMedPartners Boehringer Ingelheim Venture Fund EMBL Ventures Epidarex Capital Gimv Vesalius Biocapital Partners
3/2016	Series A	3	$15.7M	EMBL Ventures Epidarex Capital Gimv EMBL Ventures Epidarex Capital Gimv

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details